Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Shares of Israeli drug development company Compugen Ltd. (CGEN) are up 10 percent on Thursday's trading as the company reported a first-quarter net loss lesser than analysts' expectations.


RTTNews | May 13, 2021 10:30AM EDT

10:30 Thursday, May 13, 2021 (RTTNews.com) - Shares of Israeli drug development company Compugen Ltd. (CGEN) are up 10 percent on Thursday's trading as the company reported a first-quarter net loss lesser than analysts' expectations.

During the three-month period, Compugen reported net loss of $9.9 million or $0.12 per share, compared to net loss of $7.1 million or $0.10 per share in the same period last year.

On average, 7 analysts polled by Thomson Reuters expected the company to report net loss of $0.13 per share in the quarter. Analysts' estimates, usually, exclude one-time items.

The company's operating loss widened to $10.3 million in the first quarter from $7.39 million a year ago.

The stock was trading at $7.58, up $0.72 or 10 percent on the NYSE.

CGEN has traded between $6.74 and $19.90 during the 52-week range.

Read the original article on RTTNews ( https://www.rttnews.com/3194676/stock-alert-compugen-up-10-as-loss-narrower-than-street-view.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC